RSS-Feed abonnieren

DOI: 10.1055/a-2624-0594
Potential Protective Role of Diabetes Mellitus on Aortic Aneurysms

Abstract
Background
Prior research provided evidence that diabetes mellitus (DM) may convey protection to patients with abdominal aortic aneurysm (AAA) and/or thoracic aortic aneurysm (TAA).
Methods
We sought recent publications that support or elaborate on this concept using PubMed and Cochrane, searching for publications that combine the search terms “aortic aneurysm” and “diabetes mellitus.” We collate and summarize evidence from the literature on this topic.
Results
We examined pertinent data on AAA, TAA, and aortic aneurysms in general (AA). Patients with DM have lower risk of developing AAA and a lower rate of growth of AAA. Patients with DM have a lower risk of mortality following hospitalizations for AA. That said, however, patients with DM who undergo AAA repair show higher risk of mortality. Patients with DM have lower aneurysm diameter and lower homocysteine and D-dimer levels. Research is emerging regarding a possible genetic explanation: the gene PSMD12 may play a role in the connection between AAA and DM. Patients with AAA taking diabetic medication metformin show reduced rate of growth of AAA as well as decreased mortality and complications. In TAA, however, no statistically significant differences in mortality or complications are consistently found. We find positive evidence to support the concept that diabetes does confer protection from AAA rupture. Current data does confirm significant protective effect for TAA.
Conclusion
We confirm that metformin does exert protective properties. Diabetic protection against AAA may be mediated via Laplace's Law, as diabetic aortas have thicker walls, thus decreasing wall tension.
License Type: CC-BY
Publikationsverlauf
Eingereicht: 22. November 2024
Angenommen: 28. Mai 2025
Artikel online veröffentlicht:
04. August 2025
© 2025. The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution License, permitting unrestricted use, distribution, and reproduction so long as the original work is properly cited. (https://creativecommons.org/licenses/by/4.0/)
Thieme Medical Publishers, Inc.
333 Seventh Avenue, 18th Floor, New York, NY 10001, USA
-
References
- 1 Patel K, Zafar MA, Ziganshin BA, Elefteriades JA. Diabetes mellitus: is it protective against aneurysm? A narrative review. Cardiology 2018; 141 (02) 107-122
- 2 Leon BM, Maddox TM. Diabetes and cardiovascular disease: epidemiology, biological mechanisms, treatment recommendations and future research. World J Diabetes 2015; 6 (13) 1246-1258
- 3 Tilson MD, Seashore MR. Human genetics of the abdominal aortic aneurysm. Surg Gynecol Obstet 1984; 158 (02) 129-132
- 4 Biddinger A, Rocklin M, Coselli J, Milewicz DM. Familial thoracic aortic dilatations and dissections: a case control study. J Vasc Surg 1997; 25 (03) 506-511
- 5 Coady MA, Davies RR, Roberts M. et al. Familial patterns of thoracic aortic aneurysms. Arch Surg 1999; 134 (04) 361-367
- 6 Elefteriades JA, Zafar MA, Ziganshin BA. Genetics of aortic aneurysm disease: 10 key points for the practitioner. JTCVS Open 2024; 21: 58-63
- 7 Prasad K, Sarkar A, Zafar MA. et al. Advanced glycation end products and its soluble receptors in the pathogenesis of thoracic aortic aneurysm. Aorta (Stamford) 2016; 4 (01) 1-10
- 8 Astrand H, Rydén-Ahlgren A, Sundkvist G, Sandgren T, Länne T. Reduced aortic wall stress in diabetes mellitus. Eur J Vasc Endovasc Surg 2007; 33 (05) 592-598
- 9 Larsson SC, Wallin A, Håkansson N, Stackelberg O, Bäck M, Wolk A. Type 1 and Type 2 diabetes mellitus and incidence of seven cardiovascular diseases. Int J Cardiol 2018; 262: 66-70
- 10 Nordness MJ, Baxter BT, Matsumura J. et al. The effect of diabetes on abdominal aortic aneurysm growth over 2 years. J Vasc Surg 2022; 75 (04) 1211-1222.e1
- 11 Betancourt-Garcia MM, Vatcheva K, Thakur A. et al. Diabetes and its effect on abdominal aortic aneurysm growth rate in Hispanic patients. Ann Vasc Surg 2019; 61: 254-260
- 12 Ning X, Ding N, Ballew SH. et al. Diabetes, its duration, and the long-term risk of abdominal aortic aneurysm: the Atherosclerosis Risk in Communities (ARIC) study. Atherosclerosis 2020; 313: 137-143
- 13 Avdic T, Franzén S, Zarrouk M. et al. Reduced long-term risk of aortic aneurysm and aortic dissection among individuals with Type 2 diabetes mellitus: a nationwide observational study. J Am Heart Assoc 2018; 7 (03) e007618
- 14 Koba A, Yamagishi K, Sairenchi T. et al. Risk factors for mortality from aortic aneurysm and dissection: results from a 26-year follow-up of a community-based population. J Am Heart Assoc 2023; 12 (08) e027045
- 15 Li S, Zhang L, Zhu G, Feng R, Zhou J, Jing Z. Diabetes mellitus lowers the risk of aortic dissection: a systematic review and meta-analysis. Ann Vasc Surg 2021; 74: 209-219
- 16 Zarrouk M, Franzén S, Acosta S. et al. Long-term survival and cardiovascular morbidity after elective open aortic aneurysm repair in patients with and without Type 2 diabetes: a nationwide propensity-adjusted analysis. Ann Vasc Surg 2019; 59: 110-118
- 17 Raffort J, Lareyre F, Fabre R, Mallat Z, Pradier C, Bailly L. Nationwide study in France investigating the impact of diabetes on mortality in patients undergoing abdominal aortic aneurysm repair. Sci Rep 2021; 11 (01) 19395
- 18 Takahara M, Iida O, Tazaki J. et al. Clinical features and prognosis of patients with and without diabetes mellitus undergoing endovascular aortic aneurysm repair. BMC Endocr Disord 2022; 22 (01) 92
- 19 Taimour S, Franzén S, Zarrouk M. et al. Nationwide comparison of long-term survival and cardiovascular morbidity after acute aortic aneurysm repair in patients with and without Type 2 diabetes. J Vasc Surg 2020; 71 (01) 30-38.e3
- 20 Taimour S, Avdic T, Franzén S. et al. Survival, cardiovascular morbidity, and reinterventions after elective endovascular aortic aneurysm repair in patients with and without diabetes: a nationwide propensity-adjusted analysis. Vasc Med 2019; 24 (06) 539-546
- 21 Xu F, Wang W, Lei CX, Yang D, Chen YX, Zheng YH. [Influencing factors of diabetes mellitus on abdominal aortic aneurysm diameter and biochemical parameters]. Zhongguo Yi Xue Ke Xue Yuan Xue Bao 2022; 44 (03) 392-397
- 22 Morris DR, Sherliker P, Clack R. et al. Opposite associations of aortic aneurysm with blood glucose and with diabetes mellitus. Circulation 2019; 140 (03) 264-266
- 23 Zu HL, Hou LK, Liu HW, Zhan YB, He J. Identify candidate genes in the interaction between abdominal aortic aneurysm and Type 2 diabetes mellitus by using biomedical discovery support system. Chin Med Sci J 2021; 36 (01) 50-56
- 24 Morris DR, Jones GT, Holmes MV. et al. Genetic predisposition to diabetes and abdominal aortic aneurysm: a two stage Mendelian randomisation study. Eur J Vasc Endovasc Surg 2022; 63 (03) 512-519
- 25 Itoga NK, Rothenberg KA, Suarez P. et al. Metformin prescription status and abdominal aortic aneurysm disease progression in the U.S. veteran population. J Vasc Surg 2019; 69 (03) 710-716.e3
- 26 Turowicz A, Kobecki J, Laskowska A, Wojciechowski J, Świątkowski F, Chabowski M. Association of metformin and abdominal aortic aneurysm repair outcomes. Ann Vasc Surg 2021; 75: 390-396
- 27 Sutton SS, Magagnoli J, Cummings TH, Hardin JW. Association between metformin and abdominal aortic aneurysm in diabetic and non-diabetic US veterans. J Investig Med 2020; 68 (05) 1015-1018
- 28 Ortega R, Collado A, Selles F. et al. SGLT-2 (sodium-glucose cotransporter 2) inhibition reduces Ang II (Angiotensin II)-induced dissecting abdominal aortic aneurysm in ApoE (apolipoprotein E) knockout mice. Arterioscler Thromb Vasc Biol 2019; 39 (08) 1614-1628
- 29 Summers SP, Rastogi V, Yadavalli SD. et al. The association between diabetes mellitus and its management with outcomes following endovascular repair for descending thoracic aortic aneurysm. J Vasc Surg 2023; 78 (02) 313-323
- 30 Gambardella I, Worku B, Lau C. et al. Diabetes mellitus is an independent predictor of spinal cord injury after descending thoracic and thoracoabdominal aneurysm repair: maximum likelihood conditional regression in a propensity-score matched cohort. Ann Surg 2023; 278 (02) e382-e388
- 31 Wu J, Zafar MA, Liu Y. et al. Fate of the unoperated ascending thoracic aortic aneurysm: three-decade experience from the Aortic Institute at Yale University. Eur Heart J 2023; 44 (43) 4579-4588
- 32 Kalogerakos PD, Zafar MA, Li Y. et al. Root dilatation is more malignant than ascending aortic dilation. J Am Heart Assoc 2021; 10 (14) e020645